Biseokeaniamide C
| Internal ID | d737232d-3982-43e7-bcbe-a7a2b157a746 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Alpha amino acids and derivatives > Leucine and derivatives |
| IUPAC Name | (2S)-1-[(2S)-2-(butanoylamino)-3-methylbutanoyl]-N-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[methyl-[(2S)-3-methyl-1-[methyl(1,3-thiazol-2-ylmethyl)amino]-1-oxobutan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C41H63N7O6S/c1-11-16-33(49)44-35(27(4)5)40(53)48-21-15-19-31(48)39(52)46(9)32(24-29-17-13-12-14-18-29)37(50)43-30(23-26(2)3)38(51)47(10)36(28(6)7)41(54)45(8)25-34-42-20-22-55-34/h12-14,17-18,20,22,26-28,30-32,35-36H,11,15-16,19,21,23-25H2,1-10H3,(H,43,50)(H,44,49)/t30-,31-,32-,35-,36-/m0/s1 |
| InChI Key | YUSHRJINPQIDME-XGQIDOAOSA-N |
| Popularity | 4 references in papers |
| Molecular Formula | C41H63N7O6S |
| Molecular Weight | 782.00 g/mol |
| Exact Mass | 781.45605393 g/mol |
| Topological Polar Surface Area (TPSA) | 181.00 Ų |
| XlogP | 5.40 |
| Atomic LogP (AlogP) | 4.12 |
| H-Bond Acceptor | 8 |
| H-Bond Donor | 2 |
| Rotatable Bonds | 19 |
| CHEMBL4207917 |
| DTXSID201334024 |
| BDBM50450892 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.8504 | 85.04% |
| Caco-2 | - | 0.8509 | 85.09% |
| Blood Brain Barrier | - | 0.6000 | 60.00% |
| Human oral bioavailability | - | 0.7429 | 74.29% |
| Subcellular localzation | Lysosomes | 0.5208 | 52.08% |
| OATP2B1 inhibitior | - | 0.5666 | 56.66% |
| OATP1B1 inhibitior | + | 0.8504 | 85.04% |
| OATP1B3 inhibitior | + | 0.9308 | 93.08% |
| MATE1 inhibitior | - | 0.8000 | 80.00% |
| OCT2 inhibitior | - | 0.8750 | 87.50% |
| BSEP inhibitior | + | 0.8290 | 82.90% |
| P-glycoprotein inhibitior | + | 0.7646 | 76.46% |
| P-glycoprotein substrate | + | 0.8490 | 84.90% |
| CYP3A4 substrate | + | 0.7262 | 72.62% |
| CYP2C9 substrate | + | 0.6171 | 61.71% |
| CYP2D6 substrate | - | 0.8502 | 85.02% |
| CYP3A4 inhibition | - | 0.6118 | 61.18% |
| CYP2C9 inhibition | - | 0.8042 | 80.42% |
| CYP2C19 inhibition | - | 0.5082 | 50.82% |
| CYP2D6 inhibition | - | 0.9122 | 91.22% |
| CYP1A2 inhibition | - | 0.8653 | 86.53% |
| CYP2C8 inhibition | + | 0.5960 | 59.60% |
| CYP inhibitory promiscuity | - | 0.8011 | 80.11% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | - | 0.8300 | 83.00% |
| Carcinogenicity (trinary) | Non-required | 0.6521 | 65.21% |
| Eye corrosion | - | 0.9887 | 98.87% |
| Eye irritation | - | 0.9163 | 91.63% |
| Skin irritation | - | 0.7701 | 77.01% |
| Skin corrosion | - | 0.9047 | 90.47% |
| Ames mutagenesis | - | 0.6900 | 69.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7337 | 73.37% |
| Micronuclear | + | 0.5800 | 58.00% |
| Hepatotoxicity | + | 0.7773 | 77.73% |
| skin sensitisation | - | 0.8733 | 87.33% |
| Respiratory toxicity | + | 0.8222 | 82.22% |
| Reproductive toxicity | + | 0.8778 | 87.78% |
| Mitochondrial toxicity | + | 0.9125 | 91.25% |
| Nephrotoxicity | - | 0.7992 | 79.92% |
| Acute Oral Toxicity (c) | III | 0.6944 | 69.44% |
| Estrogen receptor binding | + | 0.8000 | 80.00% |
| Androgen receptor binding | + | 0.6317 | 63.17% |
| Thyroid receptor binding | + | 0.5956 | 59.56% |
| Glucocorticoid receptor binding | + | 0.6771 | 67.71% |
| Aromatase binding | + | 0.5636 | 56.36% |
| PPAR gamma | + | 0.7508 | 75.08% |
| Honey bee toxicity | - | 0.7430 | 74.30% |
| Biodegradation | - | 0.7750 | 77.50% |
| Crustacea aquatic toxicity | - | 0.5200 | 52.00% |
| Fish aquatic toxicity | + | 0.9068 | 90.68% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.95% | 98.95% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 99.44% | 90.17% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 99.11% | 98.33% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.78% | 96.09% |
| CHEMBL3492 | P49721 | Proteasome Macropain subunit | 98.35% | 90.24% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 95.96% | 93.10% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 95.37% | 97.64% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 93.77% | 98.24% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 92.50% | 93.56% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 92.50% | 99.17% |
| CHEMBL3202 | P48147 | Prolyl endopeptidase | 91.98% | 90.65% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 91.51% | 90.00% |
| CHEMBL1907599 | P05556 | Integrin alpha-4/beta-1 | 90.86% | 92.86% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 90.85% | 93.00% |
| CHEMBL4393 | P39900 | Matrix metalloproteinase 12 | 90.71% | 92.22% |
| CHEMBL3837 | P07711 | Cathepsin L | 88.90% | 96.61% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 88.79% | 100.00% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 88.58% | 97.50% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 87.85% | 95.56% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 87.81% | 97.14% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 87.77% | 100.00% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 86.60% | 91.19% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 84.98% | 97.50% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 84.72% | 99.23% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 84.30% | 100.00% |
| CHEMBL332 | P03956 | Matrix metalloproteinase-1 | 84.24% | 94.50% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 83.86% | 96.00% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 83.82% | 90.08% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 83.74% | 90.71% |
| CHEMBL3004 | P33527 | Multidrug resistance-associated protein 1 | 82.67% | 96.37% |
| CHEMBL1741221 | Q9Y4P1 | Cysteine protease ATG4B | 82.61% | 87.50% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 82.01% | 95.89% |
| CHEMBL3902 | P09211 | Glutathione S-transferase Pi | 81.11% | 93.81% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 80.75% | 96.90% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 80.51% | 98.10% |
| CHEMBL2801 | Q13557 | CaM kinase II delta | 80.36% | 84.49% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 80.19% | 95.50% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139589701 |
| LOTUS | LTS0021428 |
| wikiData | Q104203103 |